Skip to main content
Premium Trial:

Request an Annual Quote

ELIXIR Becomes Independent Legal Entity

Premium

The European Bioinformatics Institute said this week that the European Life-science Infrastructure for Biological Information (ELIXIR) project has become an independent legal entity.

The transition occurred after Estonia became the fifth country to ratify the ELIXIR Consortium Agreement. Other signatories include the United Kingdom, Sweden, Switzerland, the Czech Republic, and the European Molecular Biology Laboratory.

According to the EBI, this marks the formal launch of the infrastructure for biological data that will support life science research in Europe, and its translation to medicine, the bio-industries, and society

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.